Histamine, serotonin and triiodothyronine (T 3 ) content of different circulating lymphocyte subsets of leukemic (acute lymphocytic leukemia, ALL) and non-leukemic (control) children were investigated by multicolor flow cytometry. The hormone contents of the cells were followed from the time of diagnosis till the end of treatment. Each hormone could be detected in every time in the investigated cell types, although the amounts of them changed during the treatment.
Introduction
There is a close connection between the immune and neuroendocrine systems. Trop-hormones of the pituitary gland influence the function of immune cells, and products of other endocrine glands also have targets on the specific receptors of immune cells [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . In addition, the immune cells (lymphocytes, monocytes, granulocytes and mast cells) contain hormone-like neurotransmitters and real hormones, which are also able to influence immune functions [10] [11] [12] [13] . Thus, histamine and serotonin, which are present in immune cells, participate in normal and pathological immune reactions [1, [14] [15] [16] , endorphin calms pain during inflammation and endorphin insulin, ACTH and triiodothyronine (T 3 ) have an immunomodulatory function [17] [18] [19] [20] [21] [22] . The T 3 of the immune cells is regulated by TSH, similar to those of the thyroid gland [23] . The receptors of immune cells for hormones are identical to those of the other target cells [8] .
Most of the experiments aiming to clarify the presence and function of hormones in immune cells were carried out in animals. However, these hormones are present also in human immune cells, in which histamine, serotonin, epinephrine, T 3 , endorphin and ACTH were demonstrated and mapped for different cell types and subsets in healthy persons [24, 25] . The question is, whether the hormone content of human immune cells is altered or not during pathological conditions. The aim of the present experiments to evaluate the changes of hormone contents in children having acute lymphocytic leukemia (ALL) before, during and after treatment and to compare that of the control persons.
Materials and Methods

Subjects
Thirty-four children (1.5-17 years old) treated in the 2nd Dept. of Pediatrics of Semmelweis University were enrolled in the study: 6 controls (not having hematological disease), 10 in the time of ALL diagnosis, 9 during maintenance therapy (at eight months as a mean after ending the intensive therapy) and 9 after finishing the treatment (2.2 years as a mean after finishing the maintenance therapy). Children were treated according to the ALL IC-BFM2002 international protocol. Written consent for the experiments was obtained from the parents after a statement of participation was read. The study was approved by the Ethical Community of the Semmelweis University according to the Helsinki Declaration.
Blood collection
Peripheral venous blood samples were prevented from clotting using Vacutainer® Brand PLUS K2 EDTA Tubes (Becton Dickinson, San Jose, CA, USA). Collected venous blood was divided into two parts: one for the clinical investigations and the other to the research measurements.
Sample preparation for flow cytometric analysis
All the antibodies used for the characterization of different cell populations were manufactured by BD Biosciences (San Jose, Ca, USA). Erythrocytes were lysed after incubation with monoclonal antibodies, following a protocol for simultaneous cell surface and intracellular labeling (FACSLysing, BD Biosciences, San Jose, Ca, USA) [26] and leukocytes were washed with PBS. Lysed and washed cells were fixed by 4% paraformaldehyde (Sigma-Aldrich, St. Louis, Mo) and permeabilized by 0.1% saponin solution (Sigma) for staining of intracellular T 3 and serotonin. For histamine detection EDAC was used for fixation instead of paraformaldehyde. Before the measurements, cells were washed with 0.1% saponin solution and fixed by 2% paraformaldehyde solution (Sigma-Aldrich, St. Louis, Mo).
Detection of lymphocyte populations in the peripheral blood
Anticoagulated whole blood (100 µl/tube) was incubated with fluorochrome-conjugated monoclonal antibodies for 25 minutes at room temperature. Optimal amounts of antibodies were determined earlier. The antibodies were diluted according to the product description and the dilutions were controlled at the first application [19] . Fluorochrome-conjugated anti-human CD3, anti-human CD19 and anti-human CD56 antibodies were used for the determination of the frequencies of T cells, B cells and NK cells, respectively.
Cell surface expression of CD4, CD8, and HLA-DR were determined to assess the T cell subpopulations and activated T cells.
The lymphocyte gate was determined according to the size and granularity by the FS/SS (forward scatter/side scatter) dot plot. The purity of gate was detected by CD45/CD14 labeling. The lymphocyte gate was set considering the amount of CD45+ lymphocytes (more than 95%) and the ratio of CD45+/CD14+ monocytes (less than 3%).
Parallel measurements were done. Isotype control antibodies were used for the detection of unspecific staining.
Flow cytometric analysis of the hormone content
The hormone content of permeabilized cells was detected with affinity isolated highly antigen-specific antibodies to histamine [H-7403, Lot, 51K4855], serotonin [S-5545, Lot 075K4779] and triiodothyronine (T 3 , produced in rabbit, by Sigma, USA) used as primary antibody, and FITC-labelled anti-rabbit FITC-IgG (Sigma; [F-9887, Lot. 063K4816]), as secondary antibody. For controlling the specificity, autofluorescence of the cells and unspecific staining with the secondary antibodies were detected. The measurement was done with a FACSCalibur flow cytometer (Becton Dickinson, San Jose, USA), using 25,000 cells for each measurement. For the analysis of results CellQuest Pro program was used.
During the evaluation, lymphocyte populations were defined by their immunophenotype. Histamine, serotonin and T 3 content (concentration) of different cell types were compared at different time points (at the time of diagnosis, during maintenance therapy and after treatment, related to the control). The numerical comparison of detected values was done by the comparison of percentual changes of geometric mean channel values (Geo-mean). Student's t-test of Origin program was used for determining significance between the groups.
Results and Discussion
Considering the observation that human immune cells contain hormones, the aims of the present experiments were to examine 1) the effect of a hematological malignant disease, ALL, on this hormone level, and 2) to investigate the influence of the treatment on the hormone level. Three hormones were chosen as indices: two biogenic amines, histamine and serotonin, both having well-known important regulatory functions in the immune system [1, 14, 15] , and T 3 , the function of which is less known in the immune system. However, T 3 is present in each immune cell and its level is influenced similarly to the identical hormone of the thyroid gland [11, 23] . The amount of hormones was demonstrated by flow cytometry. The values obtained in samples of children with active disease, during and after treatment were compared with each other, and to the control (hematologically healthy) children. However, not the values measured in the same patients, but that of the groups of different patients being in similar conditions were followed.
The first and perhaps the most important observation is that the amount of serotonin significantly decreased (compared to the controls) in the ALL children in each set and subset of lymphocytes (Tables II and V) . This decrease sustained during maintenance therapy. Years after finishing the treatment, this decrease was also observed, except in activated T lymphocytes. On the other hand, histamine and T 3 content (Tables I, III, n.s. = not significant; T = T cells; Tc = cytotoxic T cells; Th = helper T cells; Tact = activated T cells ALL. However, during maintenance therapy, both hormones decreased in each subset, except for histamine in Tc and Th cells. And while histamine content did not decrease after treatment, the amount of T 3 was significantly reduced, but only in the Tc and Th cells. The presence of histamine in ALL cells was demonstrated earlier and it was supposed that histamine is an autocrine regulator of ALL cell proliferation [27] . Other authors observed histamine-induced cyclic AMP synthesis in ALL cells [28] . Considering these data, the unchanged histamine level in the ALL cells is surprising. However, there are no data on the role of T 3 in ALL, and in normal immune cells, since even the knowledge on the presence of this hormone in the immune cells is relatively new [11] . Nevertheless, it is interesting that plasma T 3
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A decrease of the serotonin hormone content (compared to the control) was observed in each state of the investigation. However, for the other two hormones the decrease appeared only during maintenance treatment and this remained unchanged years after the end of the therapy. This indicates -and makes likely also in the case of serotonin -that the therapy causes the persistence of the hormone decrease.
The presence of serotonin in lymphocytes was demonstrated by us earlier [25] . In the present investigation the decrease of serotonin content was the most characteristic change observed of all the hormones studied. The significant de- crease detected at the time of diagnosis points to the possibility that serotonin could serve as a diagnostic index. However, the role of serotonin in the leukemic process is not known. Still, its persistent and therapy independent decrease points to its possible role in the essential immune modulation of the leukemic process. It would be interesting to see how serotonin levels change on the long term, for example 10 years after treatment, or in relapsed patients. This way it may serve as a prognostic factor as well.
The results call attention to the selective change of cellular hormone levels during a pathological process, and points to the selective hormone response. Considering these observations, the possibility of prognostic value of hormone content is also suggested. At present, two biogenic amines and one real hormone were studied. However, this latter is also an amino-acid type simple hormone (T 3 ). It can be suggested that the study of more -especially peptide -hormones in ALL, which are also present in normal immune cells, can broaden our knowledge on the prognostic value of hormone levels in hematological diseases.
